Related references
Note: Only part of the references are listed.Reporting bias in diagnostic and prognostic studies: Time for action
Nader Rifai et al.
CLINICAL CHEMISTRY (2008)
Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies
J. A. Hayden et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?
Daniel F. Hayes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Meta-analysis of continuous outcomes combining individual patient data and aggregate data
Richard D. Riley et al.
STATISTICS IN MEDICINE (2008)
Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing?
Rivka Ravid
CELL AND TISSUE BANKING (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Almost all articles on cancer prognostic markers report statistically significant results
Panayiotis A. Kyzas et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prognosis research: toward evidence-based results and a Cochrane methods group
Richard D. Riley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Author reply: improving prognosis research: standards primary, secondary, and tertiary
Harry Hemingway
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program
Martin Filipits et al.
CLINICAL CANCER RESEARCH (2007)
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer:: The international adjuvant lung cancer trial biologic program
Martin Filipits et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Opinion - Shaping the future of biomarker research in breast cancer to ensure clinical relevance
M. Carolina Hinestrosa et al.
NATURE REVIEWS CANCER (2007)
Quality of reporting of cancer prognostic marker studies: Association with reported prognostic effect
Panayiotis A. Kyzas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
Alain Dupuy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The challenges of gene expression microarrays for the study of human cancer
Anna V. Tinker et al.
CANCER CELL (2006)
Evaluation of the quality of prognosis studies in systematic reviews
JA Hayden et al.
ANNALS OF INTERNAL MEDICINE (2006)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Individual survival time prediction using statistical models
R Henderson et al.
JOURNAL OF MEDICAL ETHICS (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Risk of cancer after low doses of ionising radiation - retrospective cohort study in 15 countries
E Cardis et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes
CT Smith et al.
STATISTICS IN MEDICINE (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mortality among workers employed in the titanium dioxide production industry in Europe
P Boffetta et al.
CANCER CAUSES & CONTROL (2004)
Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present
RD Riley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
A Burton et al.
BRITISH JOURNAL OF CANCER (2004)
The International Bladder Cancer Bank:: proposal for a new study concept
PJ Goebell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2004)
A systematic review of molecular and biological tumor markers in neuroblastoma
RD Riley et al.
CLINICAL CANCER RESEARCH (2004)
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker
MS Pepe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin et al.
BRITISH JOURNAL OF CANCER (2003)
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
RD Riley et al.
BRITISH JOURNAL OF CANCER (2003)
Review of analytical methods for prospective cohort studies using time to event data: single studies and implications for meta-analysis
DA Bennett
STATISTICAL METHODS IN MEDICAL RESEARCH (2003)
Prognostic factors in non-small cell lung cancer - A decade of progress
MD Brundage et al.
CHEST (2002)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
MP Look et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables
DG Altman
BMJ-BRITISH MEDICAL JOURNAL (2001)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Does age influence the behaviour of localized prostate cancer?
CC Parker et al.
BJU INTERNATIONAL (2001)
p53 immunohistochemistry as a prognostic marker in bladder cancer -: Playground for urology scientists?
BJ Schmitz-Dräger et al.
EUROPEAN UROLOGY (2000)